Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer
Kentaro Inamura, 2017, Cells CrossRef
miR-155 mediates arsenic trioxide resistance by activating Nrf2 and suppressing apoptosis in lung cancer cells
Shiyan Gu et al, 2017, Sci Rep CrossRef
miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.
Recep Bayraktar et al, 2018, Cancer Metastasis Rev CrossRef
miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway
Lin Wang et al, 2018, Cancer Biotherapy and Radiopharmaceuticals CrossRef
Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells
Xin Liu, 2018, Biomedicine & Pharmacotherapy CrossRef
Simultaneous downregulation of miR-21 and miR-155 through oleuropein for breast cancer prevention and therapy
Maryam Abtin et al, 2018, J. Cell. Biochem. CrossRef
Capturing intracellular oncogenic microRNAs with self-assembled DNA nanostructures for microRNA-based cancer therapy
Q. Liu et al, 2018, Chem. Sci. CrossRef
MicroRNA-155 regulates arsenite-induced malignant transformation by targeting Nrf2-mediated oxidative damage in human bronchial epithelial cells
Chengzhi Chen et al, 2017, Toxicology Letters CrossRef
A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes
Qing Zhou et al, 2018, Regulatory Toxicology and Pharmacology CrossRef
Characterization of the breast cancer resistance protein (BCRP/ABCG2 ) in clear cell renal cell carcinoma
Anna Reustle et al, 2018, Int. J. Cancer CrossRef
MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma
Hanne Due et al, 2019, Blood Adv CrossRef
Environmental Arsenic Exposure and Human Health Risk
Anindita Mitra et al, 2020 CrossRef
IL-27 in Health and Disease
Marek Jankowski et al, 2016 CrossRef
Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study
null Morini et al, 2019, Cancers CrossRef
Amphiphilic polypeptide P23: design, synthesis, self-assembly and its encapsulation effect on doxorubicin
Fei Ge et al, 2019, Mater. Res. Express CrossRef
MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc.
Li Tao et al, 2020, Biomed Pharmacother CrossRef
The current state of MiRNAs as biomarkers and therapeutic tools
Ilgiz Gareev et al, 2020, Clin Exp Med CrossRef
miR‑125b regulates the drug‑resistance of breast cancer cells to doxorubicin by targeting HAX‑1
Guinv Hu et al, 2017, Oncol Lett CrossRef
MicroRNA-155 increases colon cancer chemoresistance to cisplatin by targeting forkhead box O3
Yuewen Gao et al, 2018, Oncol Lett CrossRef
Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression
Xuefei Zhang et al, 2020, Cell Death Dis CrossRef
The role of extracellular vesicle microRNAs in cancer biology.
Ryou-U Takahashi et al, 0 CrossRef
Anthracycline-induced cardiomyopathy: cellular and molecular mechanisms
Keith Dadson et al, 2020 CrossRef
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
Katrien Van Roosbroeck et al, 2017, Clin Cancer Res CrossRef
The role of miRNAs and lncRNAs in conferring resistance to doxorubicin
Mohammad Taheri et al, 2021, Journal of Drug Targeting CrossRef
Albumin-Based Nanoparticles for the Delivery of Doxorubicin in Breast Cancer
Rama Prajapati et al, 2021, Cancers CrossRef
Ferroptosis and Cancer: Complex Relationship and Potential Application of Exosomes.
Shuang Wu et al, 2021, Front Cell Dev Biol CrossRef
Combination of 7-O-geranylquercetin and microRNA-451 enhances antitumor effect of Adriamycin by reserving P-gp-mediated drug resistance in breast cancer
Yuling Chen et al, 2022, Aging CrossRef
Emerging role of miRNAs in the regulation of ferroptosis
Reza Mahmoudi-Lamouki et al, 2023, Front. Mol. Biosci. CrossRef
Doxorubicin and Cisplatin Modulate miR-21, miR-106, miR-126, miR-155 and miR-199 Levels in MCF7, MDA-MB-231 and SK-BR-3 Cells That Makes Them Potential Elements of the DNA-Damaging Drug Treatment Response Monitoring in Breast Cancer Cells—A Preliminary Study
Anna Mizielska et al, 2023, Genes CrossRef
The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis
Yanan Wu et al, 2023, Mol Diagn Ther CrossRef
Noncoding RNAs in cancer ferroptosis: From biology to clinical opportunity
Chan Shan et al, 2023, Biomedicine & Pharmacotherapy CrossRef
Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells
Amirhosein Maharati et al, 2023, Cell Div CrossRef
Oxygen-producing and pH-responsive targeted DNA nanoflowers for enhanced chemo-sonodynamic therapy of lung cancer
Hongjian Liao et al, 2024, Materials Today Bio CrossRef
A Versatile Virus‐Mimetic Engineering Approach for Concurrent Protein Nanocage Surface‐Functionalization and Cargo Encapsulation
Yujie Sheng et al, 2024, Small CrossRef
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer
Prashant Dogra et al, 2024, Mol Cancer CrossRef
Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view
Fatemeh Ebadi Meinag et al, 2024, Funct Integr Genomics CrossRef
Emerging insights: miRNA modulation of ferroptosis pathways in lung cancer
Elsayed G.E. Elsakka et al, 2024, Experimental Cell Research CrossRef
MicroRNA-mediated regulation of Ferroptosis: Implications for disease pathogenesis and therapeutic interventions
Shokufeh Razi et al, 2024, Cellular Signalling CrossRef
MiRNAs function in the development of resistance against doxorubicin in cancer cells: targeting ABC transporters
Xin-Yan Lu et al, 2024, Front. Pharmacol. CrossRef
Low miR-224-5p in exosomes confers colorectal cancer 5-FU resistance by upregulating S100A4
Yan-yan Yan et al, 2024, Drug Resistance Updates CrossRef